[Treatment of exudative age-related macular degeneration: Consensus of French experts for first-line treatment selection and the importance of long-term risk/benefit ratio]

MLA

A, Couturier, et al. “[Treatment of Exudative Age-Related Macular Degeneration: Consensus of French Experts for First-Line Treatment Selection and the Importance of Long-Term Risk/Benefit Ratio].” Journal Francais d’ophtalmologie, vol. 44, no. 7, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........755fde4666a4b8bf1c979967204f4a6c&authtype=sso&custid=ns315887.

APA

A, C., L, K., S, B., J-B, C., C, D., M-N, D., F, M., V, C., E, B., A, R., H, M., J, U., S, M., & O, S. (2021). [Treatment of exudative age-related macular degeneration: Consensus of French experts for first-line treatment selection and the importance of long-term risk/benefit ratio]. Journal Francais d’ophtalmologie, 44(7).

Chicago

A, Couturier, Kodjikian L, Baillif S, Conart J-B, Dot C, Delyfer M-N, Matonti F, et al. 2021. “[Treatment of Exudative Age-Related Macular Degeneration: Consensus of French Experts for First-Line Treatment Selection and the Importance of Long-Term Risk/Benefit Ratio].” Journal Francais d’ophtalmologie 44 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........755fde4666a4b8bf1c979967204f4a6c&authtype=sso&custid=ns315887.